Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29.5M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
5.52M
-
Shares change
-
-2.11M
-
Total reported value, excl. options
-
$9.72M
-
Value change
-
-$2.41M
-
Number of buys
-
19
-
Number of sells
-
-10
-
Price
-
$1.76
Significant Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q3 2016
43 filings reported holding MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value as of Q3 2016.
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.52M shares
of 29.5M outstanding shares and own 18.69% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (1.18M shares), VANGUARD GROUP INC (1.1M shares), BlackRock Institutional Trust Company, N.A. (449K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (428K shares), Connor, Clark & Lunn Investment Management Ltd. (405K shares), Ancora Advisors, LLC (375K shares), Iguana Healthcare Management, LLC (300K shares), DEUTSCHE BANK AG\ (261K shares), WASATCH ADVISORS INC (254K shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (128K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.